Safety, tolerability, pharmacokinetics and efficacy of HB0017, C. Jiang et al.
Вставка
- Опубліковано 19 гру 2023
- Author video for 'Safety, tolerability, pharmacokinetics and efficacy of HB0017, a humanized monoclonal antibody that targets interleukin-17A, in healthy participants and patients with moderate-to-severe plaque psoriasis'
Full article: doi.org/10.1093/bjd/ljad315 - Наука та технологія
